PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35633739-5	2022	We recently showed that SF2523, a dual activity small molecule that inhibits PI3K and BRD4, acts synergistically with the antiviral drugs remdesivir and MU-UNMC-2.	remdesivir	138-148	bromodomain containing 4	Homo sapiens	86-90	
33688653-10	2021	One Sentence Summary: Evidence of in silico designed chemotype (SF2523) targeting PI3K-alpha/mTOR/BRD4 inhibits SARS-CoV-2 infection and is highly synergistic with remdesivir.	remdesivir	164-174	bromodomain containing 4	Homo sapiens	98-102